Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|41|8|794-794

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.8, 2015-04, pp. : 794-794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome – author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 794-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corticosteroid therapy in PBC with AIH features

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 947-955

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: serum vitamin D levels in primary biliary cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 633-634

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: serum vitamin D levels in primary biliary cirrhosis – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis

By Higuchi M   Horiuchi T   Kojima T   Nishizaka H   Ishibashi H   Hayashi K   Niho Y   Nagasawa K  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 5, 1998-10 ,pp. : 429-432

Informa Healthcare

Access to resources Recommend Favorite